Over the past few years there has been a renewed interest in vitamin D as it has been found to be strongly associated with many diseases. For example intestinal inflammation, ulcerative colitis, Crohn’s disease and some cancers cancer have strong associations with vitamin D deficiency.
Irritable bowel syndrome (IBS) is a functional disorder of the gastrointestinal system affecting a large number of people worldwide. Although it doesn’t directly kill people, flatulence, bloating, distention, pain, diarrhoea and constipation have a substantial impact on patients’ quality of life. Appointments for IBS symptoms also put a large financial burden on healthcare services and patients are often forced to trialling unsafe dietary restrictions alone without professional support.
Although the role of vitamin D deficiency in irritable bowel syndrome (IBS) has not yet been established one new study tried to establish the role of vitamin D deficiency in IBS patients compared to a healthy control group.
Sixty patients with IBS and 100 healthy individuals were included as test and control groups, respectively, in the study. The average blood level (nmol/L) of IBS patients was compared to the control group levels.
Although vitamin D is common in various parts of the world, there was a statistically significant difference in the mean vitamin D level between healthy and IBS patients. Vitamin D deficiency was detected in 49 patients (82%) in the IBS group and 31 patients (31%) in the control group.
These results suggest that vitamin D should be tested in IBS patients and vitamin D supplementation could play a therapeutic role in the control of IBS.
Khayyat Y, Attar S. Vitamin D Deficiency in Patients with Irritable Bowel Syndrome: Does it Exist? Oman Medical Journal. 2015;30(2):115-118. doi:10.5001/omj.2015.25.